Replies to post #2546 on Synergy Pharmaceuticals Inc fka SGYPQ

[Opti Mist]

Money flow has turned positive in Synergy Pharmaceuticals (SGYP +10.8%) albeit on modestly higher volume. Earlier today, would-be competitor Ardelyx (ARDX -36.7%) announced positive late-stage data on IBS-C candidate tenapanor but with a 14.6% rate of diarrhea, higher that Trulance's 5% (data from studies in chronic ideopathic constipation).